LOSARTAN POTASSIUM 100 MG TAB
For 30 tablets
Pharmacies pay
$1.34 filed
30 × $0.04453 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$3.77 filed
30 × $0.12559 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
2.8× estimated
Medicare paid 2.8× what pharmacies pay.
Part D averages every strength and form sold under “Losartan Potassium” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$6.54 estimated
$1.34 + $0.20 (15%) + $5.00 fee per fill = $6.54
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
LOSARTAN POTASSIUM 100 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “losartan potassium” and “losartan”, as its NDCs’ listings variously write the nonproprietary name, under the trade names “LOSARTAN POTASSIUM 100 mg”, “Losartan potassium Tablets, 100 mg” and “Losortan Potassium”.
FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.
FDA lists 17 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, AiPing Pharmaceutical, Inc. and Camber Pharmaceuticals, Inc.
FDA’s Established Pharmacologic Class for it is Angiotensin 2 Receptor Blocker.
The NADAC file of 2026-10-14 prices it under 41 NDCs (National Drug Codes); the FDA directory lists 39 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $1.34 for 30 tablets (30 × $0.04453 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 17 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| AiPing Pharmaceutical, Inc. | 3 | $0.04453 per EA filed |
| Alembic Pharmaceuticals Inc. | 3 | $0.04453 per EA filed |
| Aurobindo Pharma Limited | 3 | $0.04453 per EA filed |
| Camber Pharmaceuticals, Inc. | 3 | $0.04453 per EA filed |
| Granules Pharmaceuticals Inc. | 3 | $0.04453 per EA filed |
| Jubilant Cadista Pharmaceuticals Inc. | 3 | $0.04453 per EA filed |
| Macleods Pharmaceuticals Limited | 3 | $0.04453 per EA filed |
| Novadoz Pharmaceuticals LLC | 3 | $0.04453 per EA filed |
| Solco Healthcare US, LLC | 3 | $0.04453 per EA filed |
| Zydus Pharmaceuticals USA Inc. | 3 | $0.04453 per EA filed |
| Lupin Pharmaceuticals, Inc. | 2 | $0.04453 per EA filed |
| NorthStar RxLLC | 2 | $0.04453 per EA filed |
| American Health Packaging | 1 | $0.04453 per EA filed |
| AvPAK | 1 | $0.04453 per EA filed |
| Major Pharmaceuticals | 1 | $0.04453 per EA filed |
| Quallent Pharmaceuticals Health LLC | 1 | $0.04453 per EA filed |
| Strides Pharma Science Limited | 1 | $0.04453 per EA filed |
| Not listed as a package in the FDA directory | 2 | $0.04453 per EA filed |
All 41 NDCs, with labeler and price
- 00904-7049-61 · Major Pharmaceuticals · $0.04453 per EA · eff. 2026-09-23 filed
- 11788-0102-10 · AiPing Pharmaceutical, Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 11788-0102-30 · AiPing Pharmaceutical, Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 11788-0102-90 · AiPing Pharmaceutical, Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 31722-0702-10 · Camber Pharmaceuticals, Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 31722-0702-30 · Camber Pharmaceuticals, Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 31722-0702-90 · Camber Pharmaceuticals, Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 33342-0046-07 · Macleods Pharmaceuticals Limited · $0.04453 per EA · eff. 2026-09-23 filed
- 33342-0046-10 · Macleods Pharmaceuticals Limited · $0.04453 per EA · eff. 2026-09-23 filed
- 33342-0046-44 · Macleods Pharmaceuticals Limited · $0.04453 per EA · eff. 2026-09-23 filed
- 43547-0362-03 · Solco Healthcare US, LLC · $0.04453 per EA · eff. 2026-09-23 filed
- 43547-0362-09 · Solco Healthcare US, LLC · $0.04453 per EA · eff. 2026-09-23 filed
- 43547-0362-11 · Solco Healthcare US, LLC · $0.04453 per EA · eff. 2026-09-23 filed
- 50268-0506-11 · not listed as a package in the FDA directory · $0.04453 per EA · eff. 2026-09-23 filed
- 50268-0506-15 · AvPAK · $0.04453 per EA · eff. 2026-09-23 filed
- 59746-0335-10 · Jubilant Cadista Pharmaceuticals Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 59746-0335-30 · Jubilant Cadista Pharmaceuticals Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 59746-0335-90 · Jubilant Cadista Pharmaceuticals Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 62332-0029-30 · Alembic Pharmaceuticals Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 62332-0029-90 · Alembic Pharmaceuticals Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 62332-0029-91 · Alembic Pharmaceuticals Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 64380-0935-05 · Strides Pharma Science Limited · $0.04453 per EA · eff. 2026-09-23 filed
- 65862-0203-30 · Aurobindo Pharma Limited · $0.04453 per EA · eff. 2026-09-23 filed
- 65862-0203-90 · Aurobindo Pharma Limited · $0.04453 per EA · eff. 2026-09-23 filed
- 65862-0203-99 · Aurobindo Pharma Limited · $0.04453 per EA · eff. 2026-09-23 filed
- 68084-0348-01 · American Health Packaging · $0.04453 per EA · eff. 2026-09-23 filed
- 68084-0348-11 · not listed as a package in the FDA directory · $0.04453 per EA · eff. 2026-09-23 filed
- 68180-0378-03 · Lupin Pharmaceuticals, Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 68180-0378-09 · Lupin Pharmaceuticals, Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 68382-0137-06 · Zydus Pharmaceuticals USA Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 68382-0137-10 · Zydus Pharmaceuticals USA Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 68382-0137-16 · Zydus Pharmaceuticals USA Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 70010-0743-03 · Granules Pharmaceuticals Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 70010-0743-09 · Granules Pharmaceuticals Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 70010-0743-10 · Granules Pharmaceuticals Inc. · $0.04453 per EA · eff. 2026-09-23 filed
- 72205-0143-30 · Novadoz Pharmaceuticals LLC · $0.04453 per EA · eff. 2026-09-23 filed
- 72205-0143-90 · Novadoz Pharmaceuticals LLC · $0.04453 per EA · eff. 2026-09-23 filed
- 72205-0143-99 · Novadoz Pharmaceuticals LLC · $0.04453 per EA · eff. 2026-09-23 filed
- 72603-0342-01 · NorthStar RxLLC · $0.04453 per EA · eff. 2026-09-23 filed
- 72603-0342-02 · NorthStar RxLLC · $0.04453 per EA · eff. 2026-09-23 filed
- 82009-0044-10 · Quallent Pharmaceuticals Health LLC · $0.04453 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
5 other products in the NADAC file share an FDA nonproprietary name with LOSARTAN POTASSIUM 100 MG TAB.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| COZAAR 25 MG TABLET | $3.36363 per EA filed | $4.52796 per EA filed |
| COZAAR 50 MG TABLET | $4.49351 per EA filed | $4.52796 per EA filed |
| COZAAR 100 MG TABLET | $6.13999 per EA filed | $4.52796 per EA filed |
| LOSARTAN POTASSIUM 25 MG TAB | $0.02183 per EA filed | $0.12559 per EA filed |
| LOSARTAN POTASSIUM 50 MG TAB | $0.03267 per EA filed | $0.12559 per EA filed |
| LOSARTAN POTASSIUM 100 MG TAB this page | $0.04453 per EA filed | $0.12559 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 41 NDCs’ NADAC prices is $0.04453 per EA filed.
Of the 107 other products in FDA’s Angiotensin 2 Receptor Blocker class priced per EA, 105 have a higher middle NADAC price and 2 a lower one. The one in the middle is OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5, at $1.15137 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $3.77 for 30 tablets, at an average of $0.12559 per EA in 2024 (2024-01-01 to 2024-12-31) for “Losartan Potassium”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 36,240,406 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for LOSARTAN POTASSIUM 100 MG TAB labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Losartan Potassium / Losartan Potassium: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB
- VALSARTAN 160 MG TABLET
- ENTRESTO 24 MG-26 MG TABLET
- OLMESARTAN MEDOXOMIL 20 MG TAB
- IRBESARTAN 150 MG TABLET